CIBMTR Reporting Implementation Guide
0.1.6 - Trial Use 1
CIBMTR Reporting Implementation Guide
0.1.6 - Trial Use 1
This page is part of the CIBMTR Reporting Implementation Guide (v0.1.6: Release Draft) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions 
| Active as of 2023-05-05 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="med-cytarabine-vs"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><ul><li>Include these codes as defined in <a href="http://www.nlm.nih.gov/research/umls/rxnorm"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>151319</td><td>Alexan</td></tr><tr><td>3041</td><td>cytarabine</td></tr><tr><td>151577</td><td>Cytosar</td></tr><tr><td>220177</td><td>Tarabine PFS</td></tr><tr><td>196337</td><td>DepoCyt</td></tr><tr><td>1942744</td><td>Vyxeos</td></tr><tr><td>1175506</td><td>Alexan Injectable Product</td></tr><tr><td>2285813</td><td>cytarabine / daunorubicin Injectable Product</td></tr><tr><td>2285807</td><td>cytarabine / daunorubicin Injection</td></tr><tr><td>331779</td><td>cytarabine 100 MG/ML</td></tr><tr><td>332422</td><td>cytarabine 20 MG/ML</td></tr><tr><td>564102</td><td>cytarabine 20 MG/ML [Alexan]</td></tr><tr><td>564515</td><td>cytarabine 20 MG/ML [Cytosar]</td></tr><tr><td>572983</td><td>cytarabine 20 MG/ML [Tarabine PFS]</td></tr><tr><td>105580</td><td>cytarabine 20 MG/ML Injectable Solution [Alexan]</td></tr><tr><td>108359</td><td>cytarabine 20 MG/ML Injectable Solution [Cytosar]</td></tr><tr><td>213044</td><td>cytarabine 20 MG/ML Injectable Solution [Tarabine PFS]</td></tr><tr><td>333668</td><td>cytarabine 50 MG/ML</td></tr><tr><td>564516</td><td>cytarabine 50 MG/ML [Cytosar]</td></tr><tr><td>108360</td><td>cytarabine 50 MG/ML Injectable Solution [Cytosar]</td></tr><tr><td>1151483</td><td>cytarabine Injectable Product</td></tr><tr><td>371676</td><td>cytarabine Injectable Solution</td></tr><tr><td>362596</td><td>cytarabine Injectable Solution [Alexan]</td></tr><tr><td>363023</td><td>cytarabine Injectable Solution [Cytosar]</td></tr><tr><td>362991</td><td>cytarabine Injectable Solution [Tarabine PFS]</td></tr><tr><td>544939</td><td>cytarabine Injectable Suspension</td></tr><tr><td>1731354</td><td>cytarabine Injection</td></tr><tr><td>968805</td><td>cytarabine liposome 10 MG/ML</td></tr><tr><td>1942738</td><td>cytarabine liposome 100 MG</td></tr><tr><td>1174486</td><td>Cytosar Injectable Product</td></tr><tr><td>1179037</td><td>Tarabine PFS Injectable Product</td></tr><tr><td>2017575</td><td>cytarabine / daunorubicin</td></tr></table></li></ul></div>
</text>
<url
value="http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/med-cytarabine-vs"/>
<version value="0.1.6"/>
<name value="RxNormCytarabineVS"/>
<title value="RxNorm - Cytarabine"/>
<status value="active"/>
<experimental value="true"/>
<date value="2023-05-05T10:50:04-05:00"/>
<publisher
value="The Medical College of Wisconsin, Inc. and the National Marrow Donor Program"/>
<contact>
<name
value="The Medical College of Wisconsin, Inc. and the National Marrow Donor Program"/>
<telecom>
<system value="url"/>
<value value="http://www.cibmtr.org"/>
</telecom>
</contact>
<contact>
<name value="Bob Milius"/>
<telecom>
<system value="email"/>
<value value="bmilius@nmdp.org"/>
</telecom>
</contact>
<description value="RxNorm codes for Cytarabine"/>
<compose>
<include>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<concept>
<code value="151319"/>
<display value="Alexan"/>
</concept>
<concept>
<code value="3041"/>
<display value="cytarabine"/>
</concept>
<concept>
<code value="151577"/>
<display value="Cytosar"/>
</concept>
<concept>
<code value="220177"/>
<display value="Tarabine PFS"/>
</concept>
<concept>
<code value="196337"/>
<display value="DepoCyt"/>
</concept>
<concept>
<code value="1942744"/>
<display value="Vyxeos"/>
</concept>
<concept>
<code value="1175506"/>
<display value="Alexan Injectable Product"/>
</concept>
<concept>
<code value="2285813"/>
<display value="cytarabine / daunorubicin Injectable Product"/>
</concept>
<concept>
<code value="2285807"/>
<display value="cytarabine / daunorubicin Injection"/>
</concept>
<concept>
<code value="331779"/>
<display value="cytarabine 100 MG/ML"/>
</concept>
<concept>
<code value="332422"/>
<display value="cytarabine 20 MG/ML"/>
</concept>
<concept>
<code value="564102"/>
<display value="cytarabine 20 MG/ML [Alexan]"/>
</concept>
<concept>
<code value="564515"/>
<display value="cytarabine 20 MG/ML [Cytosar]"/>
</concept>
<concept>
<code value="572983"/>
<display value="cytarabine 20 MG/ML [Tarabine PFS]"/>
</concept>
<concept>
<code value="105580"/>
<display value="cytarabine 20 MG/ML Injectable Solution [Alexan]"/>
</concept>
<concept>
<code value="108359"/>
<display value="cytarabine 20 MG/ML Injectable Solution [Cytosar]"/>
</concept>
<concept>
<code value="213044"/>
<display
value="cytarabine 20 MG/ML Injectable Solution [Tarabine PFS]"/>
</concept>
<concept>
<code value="333668"/>
<display value="cytarabine 50 MG/ML"/>
</concept>
<concept>
<code value="564516"/>
<display value="cytarabine 50 MG/ML [Cytosar]"/>
</concept>
<concept>
<code value="108360"/>
<display value="cytarabine 50 MG/ML Injectable Solution [Cytosar]"/>
</concept>
<concept>
<code value="1151483"/>
<display value="cytarabine Injectable Product"/>
</concept>
<concept>
<code value="371676"/>
<display value="cytarabine Injectable Solution"/>
</concept>
<concept>
<code value="362596"/>
<display value="cytarabine Injectable Solution [Alexan]"/>
</concept>
<concept>
<code value="363023"/>
<display value="cytarabine Injectable Solution [Cytosar]"/>
</concept>
<concept>
<code value="362991"/>
<display value="cytarabine Injectable Solution [Tarabine PFS]"/>
</concept>
<concept>
<code value="544939"/>
<display value="cytarabine Injectable Suspension"/>
</concept>
<concept>
<code value="1731354"/>
<display value="cytarabine Injection"/>
</concept>
<concept>
<code value="968805"/>
<display value="cytarabine liposome 10 MG/ML"/>
</concept>
<concept>
<code value="1942738"/>
<display value="cytarabine liposome 100 MG"/>
</concept>
<concept>
<code value="1174486"/>
<display value="Cytosar Injectable Product"/>
</concept>
<concept>
<code value="1179037"/>
<display value="Tarabine PFS Injectable Product"/>
</concept>
<concept>
<code value="2017575"/>
<display value="cytarabine / daunorubicin"/>
</concept>
</include>
</compose>
</ValueSet>
IG © 2020+ The Medical College of Wisconsin, Inc. and the National Marrow Donor Program
Package nmdp.fhir.cibmtr-reporting#0.1.6 based on FHIR 4.0.1. Generated 2023-05-05
Links: Table of Contents |
QA Report
HL7®, and FHIR® are the registered trademarks of Health Level Seven International
and their use of these trademarks does not constitute an endorsement by HL7.